Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#11 / 200 Total
LPA - Logistic Properties of the Americas - Stock Price Chart
TickerLPA [AMEX]
CompanyLogistic Properties of the Americas
CountryUSA
IndustryReal Estate - Development
Market Cap602.49MEPS (ttm)0.05
P/E395.01EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B4.37EPS Q/Q-133.94%
Dividend-Sales Q/Q-
Insider Own91.27%Inst Own0.84%
Insider Trans0.00%Inst Trans333.53%
Short Float1.77%Earnings-
Analyst Recom-Target Price-
Avg Volume79.51K52W Range5.59 - 525.00
May-30-24 06:00AM Logistic Properties of the Americas to Ring Opening Bell at New York Stock Exchange (Business Wire) +684.16%
May-16-24 04:12PM Logistic Properties of the Americas Announces $120 million Refinancing of Two Logistics Parks in Costa Rica and Peru (Business Wire) +9.10%
May-13-24 04:20PM Logistic Properties of the Americas Announces Leadership Structure Evolution Strengthening the Organization (Business Wire)
Mar-18-24 07:00AM LatAm Logistic Properties, S.A. Announces Milestone Lease Agreement in Peru (PR Newswire)
Mar-15-24 09:37AM two and LatAm Logistic Properties, S.A. to Hold Virtual Investor Day on Tuesday, March 19, 2024, at 2:00 p.m. ET (GlobeNewswire)
Mar-13-24 07:17PM two and LatAm Logistic Properties, S.A. Announce Effectiveness of Registration Statement on Form F-4 in Connection with Business Combination (GlobeNewswire)
Feb-20-24 09:00AM two and LatAm Logistic Properties S.A. Announce $15 Million Equity Investment at $10 per share (GlobeNewswire)
Jan-04-24 11:35AM Billionaire Louis Bacons 15 Long-Term Stock Picks (Insider Monkey)
Dec-14-23 08:15AM LatAm Logistic Properties S.A. Announces Sale of Colombia Warehouse Facility (GlobeNewswire)
Dec-12-23 08:00AM LatAm Logistic Properties S.A. and two Announce Public Filing of Registration Statement on Form F-4 in Connection with Proposed Business Combination (GlobeNewswire)
TSHA - Taysha Gene Therapies Inc - Stock Price Chart
TickerTSHA [NASD]
CompanyTaysha Gene Therapies Inc
CountryUSA
IndustryBiotechnology
Market Cap555.45MEPS (ttm)-1.16
P/E-EPS this Y56.63%
Forward P/E-EPS next Y-14.28%
PEG-EPS past 5Y-137.69%
P/S39.23EPS next 5Y-
P/B10.32EPS Q/Q62.67%
Dividend-Sales Q/Q-27.52%
Insider Own25.20%Inst Own69.91%
Insider Trans0.00%Inst Trans-1.76%
Short Float11.53%EarningsMay 14/a
Analyst Recom1.10Target Price6.95
Avg Volume2.55M52W Range0.50 - 4.32
Jun-18-24 07:30AM Taysha Gene Therapies Announces Positive Clinical Data Across Adult and Pediatric Patients from Low Dose Cohort in Ongoing REVEAL Phase 1/2 Trials Evaluating TSHA-102 in Rett Syndrome (GlobeNewswire) -26.30%
07:02AM Sanofi taps Belharra for immune drug research; AstraZenecas new cancer drug falls short (BioPharma Dive)
Jun-12-24 07:00AM Taysha Gene Therapies to Present Clinical Data from Both REVEAL Phase 1/2 Trials During Company-Hosted Webcast and at 2024 IRSF Rett Syndrome Scientific Meeting (GlobeNewswire)
Jun-07-24 08:00AM Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-03-24 04:31PM Is Taysha Gene Therapies, Inc. (NASDAQ:TSHA) the Best Gene Therapy Company? (Insider Monkey) +5.54%
04:17PM 9 Best Gene Therapy Stocks to Buy Now (Insider Monkey)
May-15-24 03:11AM Taysha Gene Therapies Inc (TSHA) Q1 2024 Earnings Call Transcript Highlights: Navigating ... (GuruFocus.com) +21.01%
May-14-24 08:57PM TSHA Stock Earnings: Taysha Gene Therapies Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace) +7.08%
05:15PM Taysha Gene Therapies, Inc. (TSHA) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
05:03PM Taysha Gene Therapies Q1 Net Loss Narrows, Revenue Declines -- Shares Down After Hours (MT Newswires)
XBIT - XBiotech Inc - Stock Price Chart
TickerXBIT [NASD]
CompanyXBiotech Inc
CountryUSA
IndustryBiotechnology
Market Cap160.22MEPS (ttm)-1.01
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-6.44%
P/S-EPS next 5Y-
P/B0.77EPS Q/Q-161.96%
Dividend-Sales Q/Q-
Insider Own35.14%Inst Own13.22%
Insider Trans0.00%Inst Trans-5.43%
Short Float3.35%Earnings-
Analyst Recom3.00Target Price10.00
Avg Volume81.32K52W Range3.51 - 9.96
Jun-18-24 11:35AM XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment for Advanced Pancreatic Cancer (GlobeNewswire) -13.49%
May-13-24 10:53AM XBIT Stock Earnings: XBiotech Reported Results for Q1 2024 (InvestorPlace)
May-10-24 01:05PM XBiotech: Q1 Earnings Snapshot (Associated Press Finance)
Mar-18-24 03:53PM XBIT Stock Earnings: XBiotech Reported Results for Q4 2023 (InvestorPlace) +12.18%
Jan-04-24 09:00AM XBiotech to Begin Constructing New R&D Facility on its 48-acre Campus (GlobeNewswire)
Nov-14-23 09:00AM Dr. Alan Kivitz to Chair XBiotech's Natrunix Program in Rheumatoid Arthritis (GlobeNewswire)
Sep-26-23 09:00AM XBiotech Announces Enrollment Completion of Phase I Clinical Trial for Hutrukin, a Novel Candidate Therapy for Stroke (GlobeNewswire)
Aug-30-23 09:00AM XBiotech Announces Enrollment Completion of Phase II, Placebo Controlled, Multicenter Study for Natrunix in Pancreatic Cancer (GlobeNewswire)
Aug-08-23 11:47AM XBiotech Announces First Patient Begins Novel Natrunix Therapy in Phase II Rheumatoid Arthritis (RA) Clinical Trial (GlobeNewswire)
Jul-25-23 11:53AM The past three years for XBiotech (NASDAQ:XBIT) investors has not been profitable (Simply Wall St.)
SLRX - Salarius Pharmaceuticals Inc - Stock Price Chart
TickerSLRX [NASD]
CompanySalarius Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap-EPS (ttm)-173.74
P/E-EPS this Y-597.92%
Forward P/E-EPS next Y12.31%
PEG-EPS past 5Y64.97%
P/S-EPS next 5Y-
P/B0.06EPS Q/Q81.69%
Dividend-Sales Q/Q-
Insider Own6.08%Inst Own-
Insider Trans0.00%Inst Trans-3.23%
Short Float-EarningsMay 09
Analyst Recom3.00Target Price26.00
Avg Volume17.87K52W Range3.09 - 12.48
Jun-17-24 08:00AM Clinical Data on Salarius Pharmaceuticals' Seclidemstat in Patients with MDS and CMML Presented at the 2024 European Hematology Association Annual Meeting (GlobeNewswire)
Jun-12-24 08:00AM Salarius Pharmaceuticals Announces 1-for-8 Reverse Stock Split (GlobeNewswire)
May-13-24 10:53PM SLRX Stock Earnings: Salarius Pharmaceuticals Beats EPS for Q1 2024 (InvestorPlace) -7.12%
04:43PM Salarius: Q1 Earnings Snapshot (Associated Press Finance)
Mar-22-24 09:52PM SLRX Stock Earnings: Salarius Pharmaceuticals Beats EPS for Q4 2023 (InvestorPlace) +5.96% -17.74%
04:34PM Salarius: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM Salarius Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire)
Feb-22-24 08:00AM Salarius Provides Update on Strategic Review Process and Plans to Support Ongoing Seclidemstat Clinical Trials by Further Reducing Expenses (GlobeNewswire)
Jan-16-24 08:00AM Salarius Pharmaceuticals Issued U.S. Patent for Next-Generation Targeted Protein Degraders (GlobeNewswire)
Jan-03-24 08:30AM Investigator-initiated Phase 1/2 Clinical Trial Using Salarius Pharmaceuticals' Seclidemstat in Combination with Azacitidine to Treat Hematologic Cancers Resumes Patient Enrollment (GlobeNewswire)
CMTL - Comtech Telecommunications Corp. - Stock Price Chart
TickerCMTL [NASD, RUT]
CompanyComtech Telecommunications Corp.
CountryUSA
IndustryCommunication Equipment
Market Cap115.87MEPS (ttm)-1.40
P/E-EPS this Y91.12%
Forward P/E8.61EPS next Y539.53%
PEG-EPS past 5Y-
P/S0.21EPS next 5Y17.00%
P/B0.44EPS Q/Q89.04%
Dividend-Sales Q/Q-6.04%
Insider Own7.06%Inst Own67.39%
Insider Trans0.00%Inst Trans-1.89%
Short Float11.98%EarningsJun 18/b
Analyst Recom3.00Target Price9.25
Avg Volume701.04K52W Range1.53 - 13.04
Jun-18-24 12:52PM CMTL Stock Earnings: Comtech Telecom Beats EPS, Misses Revenue for Q3 2024 (InvestorPlace) +87.56%
09:40AM Comtech Telecommunications (CMTL) Q3 Earnings Top Estimates (Zacks)
08:36AM Comtech: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
08:06AM Comtech Announces Third Quarter Fiscal 2024 Results and Entered into New $222.0 Million Credit Facility (Business Wire)
Jun-17-24 11:24PM Comtech to Report Third Quarter Fiscal 2024 Results and Announces New $222.0 Million Credit Facility (Business Wire)
01:22PM Comtech Telecommunications (CMTL) Delays Filings Again, Deepening Financial Uncertainty Hagens Berman (GlobeNewswire)
Jun-12-24 07:52AM Comtech Telecommunications (CMTL) Delays Filings Again, Deepening Financial Uncertainty - Hagens Berman (Newsfile)
Jun-11-24 05:32PM Comtech Telecommunications (CMTL) Stumbles After CEO Ouster and Accounting Concerns Hagens Berman (GlobeNewswire) -7.19%
Jun-10-24 12:01PM Is Comtech Telecommunications Corp. (CMTL) Stock Trading at Low Valuation? (Insider Monkey)
Jun-05-24 03:18PM Comtech Telecommunications (CMTL) Stumbles After CEO Ouster and Accounting Concerns Hagens Berman (GlobeNewswire)
ALAR - Alarum Technologies Ltd ADR - Stock Price Chart
TickerALAR [NASD]
CompanyAlarum Technologies Ltd ADR
CountryIsrael
IndustrySoftware - Infrastructure
Market Cap187.53MEPS (ttm)-1.40
P/E-EPS this Y935.71%
Forward P/E197.57EPS next Y-88.03%
PEG-EPS past 5Y78.06%
P/S6.42EPS next 5Y-
P/B10.36EPS Q/Q207.51%
Dividend-Sales Q/Q47.49%
Insider Own4.54%Inst Own7.19%
Insider Trans0.00%Inst Trans-26.90%
Short Float4.68%EarningsMay 21/b
Analyst Recom1.00Target Price35.00
Avg Volume325.20K52W Range2.07 - 40.94
Jun-06-24 07:00AM MicroCap Rodeo's Spring into Summer Conference, June 6th 2024 - 25 Presenting Companies (ACCESSWIRE)
May-21-24 12:53PM ALAR Stock Earnings: Alarum Technologies Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace) +12.25%
08:00AM Alarum Announces Q1 2024 Results (GlobeNewswire)
May-06-24 08:30AM Alarum to Release First Quarter 2024 Earnings on May 21, 2024 (GlobeNewswire)
Apr-08-24 08:30AM Alarum Estimates Record Quarterly Revenue of More Than $8.3 Million and All Time High Operating Cashflow of $3.2 Million for the First Quarter of 2024 (GlobeNewswire) +10.07%
Mar-26-24 08:30AM Alarum Announces Exciting Events Lineup and Welcomes Esteemed Advisor to NetNut's Advisory Board (GlobeNewswire) -5.07%
Mar-14-24 07:32AM Alarum Announces Record of $1.7 Million Net Profit and $2.2 Million Adjusted EBITDA in the Fourth Quarter of 2023 (GlobeNewswire) +15.37%
Mar-04-24 08:30AM Alarum to Participate in the 36th Annual Roth Conference (GlobeNewswire)
Feb-29-24 08:30AM Alarum to Release Fourth Quarter and Full Year 2023 Earnings on March 14, 2024 (GlobeNewswire) +6.64%
Feb-21-24 08:30AM Alarum: NetNut to Introduce Revolutionary AI Data Collector Product Line (GlobeNewswire)
SCNI - Scinai Immunotherapeutics Ltd ADR - Stock Price Chart
TickerSCNI [NASD]
CompanyScinai Immunotherapeutics Ltd ADR
CountryIsrael
IndustryBiotechnology
Market Cap1.99MEPS (ttm)-20.17
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y46.35%
P/S-EPS next 5Y-
P/B-EPS Q/Q-185.60%
Dividend-Sales Q/Q-
Insider Own2.25%Inst Own8.83%
Insider Trans0.00%Inst Trans-
Short Float0.97%EarningsMay 15/a
Analyst Recom1.00Target Price700.00
Avg Volume514.85K52W Range2.23 - 18.70
Jun-17-24 07:56AM Why Is Scinai Immunotherapeutics (SCNI) Stock Up 88% Today? (InvestorPlace) +60.46%
07:40AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace)
Jun-13-24 07:00AM Scinai Immunotherapeutics Announces Receipt of a Letter of Intent from the European Investment Bank Providing Specific Terms for Conversion of its Loan to Equity (PR Newswire)
Jun-07-24 07:00AM Scinai Immunotherapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement; Continues to Work with the European Investment Bank to Convert Loan to Equity to Regain Compliance with Nasdaq Minimum Shareholders' Equity Requirement (PR Newswire) -28.41%
Jun-03-24 10:52AM SCNI Stock Earnings: Scinai Immunotherapeutics Reported Results for Q4 2023 (InvestorPlace) -5.33%
May-24-24 04:01PM Scinai Immunotherapeutics Announces Receipt of a Nasdaq Staff Determination Letter Regarding Shareholders' Equity listing requirements and Hearing to Present a Plan for Regaining Compliance (PR Newswire) +12.46% -9.42%
May-15-24 04:01PM Scinai Publishes FY 2023 Financial Statements, Files Annual Report on Form 20-F and Provides Business Update (PR Newswire)
May-06-24 09:21AM Scinai Immunotherapeutics Announces Receipt of Nasdaq Delisting Notification and Appeal (PR Newswire)
Apr-10-24 07:00AM Scinai to showcase its novel biological local therapeutic for Plaque Psoriasis at Dermatology Drug Development Summit together with Prof. Michael Schn of UMG (PR Newswire)
Apr-08-24 07:00AM Scinai Immunotherapeutics' CDMO Unit Selected by Ayana Pharma to Provide Drug Development and cGMP Manufacturing Services (PR Newswire)
CYCN - Cyclerion Therapeutics Inc - Stock Price Chart
TickerCYCN [NASD]
CompanyCyclerion Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap5.99MEPS (ttm)-6.50
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y36.06%
P/S-EPS next 5Y-
P/B0.56EPS Q/Q80.65%
Dividend-Sales Q/Q-
Insider Own23.24%Inst Own39.50%
Insider Trans0.00%Inst Trans20.31%
Short Float0.86%Earnings-
Analyst Recom1.00Target Price80.00
Avg Volume2.53K52W Range1.75 - 5.25
May-08-24 08:52AM CYCN Stock Earnings: Cyclerion Therapeutics Reported Results for Q1 2024 (InvestorPlace)
Apr-05-24 06:53AM CYCN Stock Earnings: Cyclerion Therapeutics Reported Results for Q4 2023 (InvestorPlace)
Mar-24-24 03:54PM 12 Best Biotech Penny Stocks to Invest In (Insider Monkey)
Dec-04-23 08:00AM Cyclerion Appoints Regina Graul, Ph.D., as President (GlobeNewswire) -8.71%
Nov-30-23 06:16PM Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator (GlobeNewswire) +7.39% +14.06%
Aug-02-23 08:39PM The Petri Dish: Alexion buys Pfizer gene therapies in $1B deal; Peter Hecht's plan to save Cyclerion assets (American City Business Journals)
Jul-31-23 07:00AM Tisento Launches with $81 Million From Top-Tier Investor Syndicate and Promising Cyclerion Assets (GlobeNewswire) +14.15%
Jun-01-23 04:00PM Cyclerion Regains Compliance with Nasdaq Minimum Bid Price Requirement (GlobeNewswire)
May-15-23 01:00PM Cyclerion Announces Reverse Stock Split (GlobeNewswire) -14.34%
May-12-23 02:59PM Cyclerion Therapeutics to Sell Assets for $81M, CEO Transition To New Spin-Off Private Company Established By Shareholders, New Investors (Benzinga) -25.10%
ASNS - Actelis Networks Inc - Stock Price Chart
TickerASNS [NASD]
CompanyActelis Networks Inc
CountryUSA
IndustryCommunication Equipment
Market Cap9.29MEPS (ttm)-2.32
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S2.07EPS next 5Y-
P/B-EPS Q/Q54.43%
Dividend-Sales Q/Q-60.71%
Insider Own6.88%Inst Own7.96%
Insider Trans0.00%Inst Trans-47.74%
Short Float3.53%EarningsMar 26/a
Analyst Recom-Target Price-
Avg Volume2.30M52W Range0.36 - 4.60
Jun-18-24 01:08PM Boston Fed President Susan Collins speaks with Yahoo Finance, Boeing CEO testifies (Yahoo Finance Video) +84.35%
08:06AM Why Is Actelis Networks (ASNS) Stock Up 144% Today? (InvestorPlace)
07:37AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
Jun-17-24 04:30PM Actelis Partners with Carahsoft, a Major US-based IT Software and Services Company, to Expand Access for Its Cyber-Secure, Immediate Deployment IoT Connectivity to US Government Agencies (GlobeNewswire) -14.81%
Jun-06-24 04:05PM Actelis Announces Closing of Exercise of Warrants for $3 Million Gross Proceeds (GlobeNewswire) -47.04% -20.81%
08:29AM Why Is Actelis Networks (ASNS) Stock Down 37% Today? (InvestorPlace)
07:38AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace)
Jun-05-24 04:05PM Actelis Announces Exercise of Warrants for $3 Million Gross Proceeds (GlobeNewswire) +691.49%
08:04AM Why Is Actelis Networks (ASNS) Stock Up 689% Today? (InvestorPlace)
07:35AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace)
QXO - QXO Inc. - Stock Price Chart
TickerQXO [NASD]
CompanyQXO Inc.
CountryUSA
IndustrySoftware - Application
Market Cap60.57MEPS (ttm)-1.85
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S1.09EPS next 5Y-
P/B8.01EPS Q/Q-50.79%
Dividend-Sales Q/Q9.96%
Insider Own0.03%Inst Own20.40%
Insider Trans-99.92%Inst Trans361.03%
Short Float6.35%Earnings-
Analyst Recom1.00Target Price5.00
Avg Volume15.43K52W Range19.12 - 290.00
Jun-14-24 07:30AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace) -34.66%
Jun-13-24 07:42PM Correction: QXO Announces $3.5 Billion Private Placement (GlobeNewswire) +14.55%
07:00PM QXO Announces $3.5 Billion Private Placement (GlobeNewswire)
Jun-12-24 06:00AM Merger Mania: 3 Stocks to Buy as Industries Consolidate (InvestorPlace)
Jun-06-24 11:49AM QXO Announces Leadership Team and Board of Directors (GlobeNewswire) +68.61%
Jun-05-24 09:07AM Why Is SilverSun Technologies (SSNT) Stock Down 20% Today? (InvestorPlace)
07:35AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace)
03:03AM Insider Sale: CEO Mark Meller Sells Shares of SilverSun Technologies Inc (SSNT) (GuruFocus.com)
May-30-24 10:45AM SilverSun Stockholders Approve Equity Investment (ACCESSWIRE)
May-28-24 02:54PM Billionaire-Led QXO Hires Barclays Banker Ihsan Essaid as First Finance Chief (Bloomberg) +10.82%
1234567⋯10⋯20
affiliate • advertise • careers • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.